FDA Approves Moderna COVID-19 Vaccine, Prepares to Consider Pfizer COVID-19 Vaccine EUA for Young Children
The U.S. Food and Drug Administration (FDA) on Monday granted approval to a second COVID-19 vaccine. The Moderna COVID-19 vaccine received FDA approval, and the approved vaccine will be marketed as “Spikevax” for the prevention of COVID-19 in individuals 18 years of age and older. According to the FDA, Spikevax meets the FDA’s rigorous standards…
Read More »